Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help

6W63

Structure of COVID-19 main protease bound to potent broad-spectrum non-covalent inhibitor X77

Summary for 6W63
Entry DOI10.2210/pdb6w63/pdb
Descriptor3C-like proteinase, N-(4-tert-butylphenyl)-N-[(1R)-2-(cyclohexylamino)-2-oxo-1-(pyridin-3-yl)ethyl]-1H-imidazole-4-carboxamide (3 entities in total)
Functional Keywordscovid-19, sars, sars-cov-2, sars-cov, main protease, 3c-like protease, 3cl protease, 3clpro, mpro, broad-spectrum, inhibitor, proteinase, non-covalent, reversible, structural genomics, center for structural genomics of infectious diseases, csgid, antiviral protein, viral protein-inhibitor complex, viral protein/inhibitor
Biological sourceSevere acute respiratory syndrome coronavirus 2 (2019-nCoV)
Total number of polymer chains1
Total formula weight34285.13
Authors
Mesecar, A.D.,Center for Structural Genomics of Infectious Diseases (CSGID) (deposition date: 2020-03-16, release date: 2020-03-25, Last modification date: 2023-10-18)
Primary citationMesecar, A.D.
A taxonomically-driven approach to development of potent, broad-spectrum inhibitors of coronavirus main protease including SARS-CoV-2 (COVID-19)
To Be Published,
Experimental method
X-RAY DIFFRACTION (2.1 Å)
Structure validation

222036

PDB entries from 2024-07-03

PDB statisticsPDBj update infoContact PDBjnumon